Unicharm (UNICY) AI Stock Analysis

Company Guidance

In the call, Unicharm Corporation reported a 4.8% decline in sales to JPY464.2 billion and a 22% decrease in core operating income to JPY57 billion for the second quarter of fiscal year 2025. This decline was primarily attributed to a reaction to the previous year's record-high profits and reputational issues in the feminine care segment in China. The Asian market faced competitive pressures, and strategic marketing and sales promotions further impacted earnings. However, interim income attributable to the parent company increased due to JPY5.3 billion in insurance income from India and the utilization of tax loss carryforwards. The Japan business achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, marking its highest results ever recorded. Despite challenges in Asia, signs of recovery are emerging, particularly in Vietnam, and strategic investments in growth channels are expected to yield positive results from the third quarter onward. Additionally, the fiscal year forecast was revised downward due to slower recovery in Asia, while regions like Japan, North America, and the Middle East performed better than expected. The company is also committed to shareholder returns, targeting a total return ratio of 50% or more.